Study shows promise in repairing damaged myelin
April 18, 2019
OHSU researchers collaborate on potential ‘game-changer’ for people with multiple sclerosis.
Stories
Study challenges accuracy of clinical blood lead level screening tools
April 16, 2019
Evidence review leads to updated U.S. Preventative Services Task Force screening recommendations for asymptomatic children, pregnant women.
New patient-designed facilities open on Portland’s South Waterfront
April 12, 2019
OHSU’s Center for Health & Healing Building 2 and the Gary & Christine Rood Family Pavilion offer an innovative approach to patient and family experience.
Crucial ‘electrical switch’ in brain revealed in study published by Science
April 11, 2019
Native structure of a receptor may lead to finding the mechanism behind conditions like Alzheimer’s disease.
Two new patient-centered facilities will open on Friday, April 12
April 10, 2019
MEDIA ALERT: Ribbon-cutting event, followed by tours of the Center for Health & Healing Building 2 and the Gary & Christine Rood Family Pavilion.
Body donor’s rare anatomy offers valuable lessons
April 08, 2019
99-year-old rural Oregonian may have been the oldest-known person with rare, life-threatening condition.
Heavy alcohol use stunts adolescent, young adult brain growth
April 01, 2019
OHSU study is first to pinpoint a decrease in brain volume, potentially limiting lifetime learning ability.
New questions about the tradeoffs in ‘accelerated’ cancer drug studies
April 01, 2019
Cancer clinical trials that use surrogate endpoints end up saving relatively little time, a new study finds.
Pneumonia prevention: OHSU to test specialized breathing tubes
March 28, 2019
As the most common infection among sick patients in intensive care units, OHSU will begin its clinical trial to test if a specialized breathing tube can reduce the risk of pneumonia in emergency intubation situations.
Cancer startup: Drug development company acquires OHSU’s MolecularMD
March 27, 2019
By acquiring OHSU's MolecularMD, the clinical research organization ICON, based in Dublin, Ireland, has expanded its laboratory offering in molecular diagnostic testing and brings expanded testing platforms.
